LABCORP HOLDINGS INC.
LH
83 insider filings · Latest: Sep 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Mar 5 1:57 PM | Adam H SchechterDirector, President & CEO | Sale | 8,705 | $279.96 | $2.4M | 80,773(D) | View → |
| Mar 3, 2026 | Mar 3 5:23 PM | Schechter Adam H | Proposed Sale | 8,705 | $279.96 | $2.4M | — | View → |
| Feb 27, 2026 | Mar 3 3:41 PM | Der Vaart Sandra D VanEVP, Corporate Affairs | Sale | 547.54 | $284.91 | $156.0K | 2,578.947(D) | View → |
| Feb 27, 2026 | Feb 27 2:40 PM | van der Vaart Sandra D | Proposed Sale | 548 | $284.67 | $156.0K | — | View → |
| Feb 24, 2026 | Feb 26 1:25 PM | Brian J CaveneyEVP, Pres of ED, CMO & CSO | Sale | 1,500 | $286.31 | $429.5K | 30,106.923(D) | View → |
| Feb 24, 2026 | Feb 24 6:50 PM | Caveney Brian J | Proposed Sale | 1,500 | $286.31 | $429.5K | — | View → |
| Feb 19, 2026 | Feb 23 2:13 PM | Peter J WilkinsonSVP, Chief Accounting Officer | Sale | 666 | $277.94 | $185.1K | 1,852.219(D) | View → |
| Feb 11, 2026 | Feb 13 6:13 PM | Adam H SchechterDirector, President & CEO | Sale | 5,273 | $284.38 | $1.5M | 87,343(D) | View → |
| Feb 12, 2026 | Feb 13 6:11 PM | Jonathan C MeltzerEVP, Operations | Sale | 87 | $290.42 | $25.3K | 2,782.326(D) | View → |
| Feb 10, 2026 | Feb 12 8:44 PM | Jonathan C MeltzerEVP, Operations | Sale | 91 | $276.79 | $25.2K | 2,696.326(D) | View → |
| Feb 12, 2026 | Feb 12 2:49 PM | Meltzer Jonathan C | Proposed Sale | 87 | $290.42 | $25.3K | — | View → |
| Feb 11, 2026 | Feb 11 5:59 PM | Schechter Adam H | Proposed Sale | 5,273 | $284.38 | $1.5M | — | View → |
| Feb 9, 2026 | Feb 10 8:04 PM | Jonathan C MeltzerEVP, Operations | Sale | 88 | $275.53 | $24.2K | 2,869.326(D) | View → |
| Feb 10, 2026 | Feb 10 3:30 PM | Meltzer Jonathan C | Proposed Sale | 91 | $276.79 | $25.2K | — | View → |
| Feb 9, 2026 | Feb 9 6:30 PM | Meltzer Jonathan C | Proposed Sale | 88 | $275.53 | $24.2K | — | View → |
| Nov 11, 2025 | Nov 12 11:54 AM | Schechter Adam H | Proposed Sale | 5,745 | $262.75 | $1.5M | — | View → |
| Oct 31, 2025 | Oct 31 7:16 PM | Parham Richelle P | Proposed Sale | 7,009 | $254.28 | $1.8M | — | View → |
| Aug 13, 2025 | Aug 13 4:49 PM | van der Vaart Sandra D | Proposed Sale | 3,903 | $271.42 | $1.1M | — | View → |
| Aug 11, 2025 | Aug 11 1:50 PM | Schechter Adam H | Proposed Sale | 5,643 | $266.78 | $1.5M | — | View → |
| Jul 24, 2025 | Jul 24 8:24 PM | KERRII ANDERSON | Proposed Sale | 3,500 | $250.51 | $876.8K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Sep 3 12:21 PM | Akinbolade OyegunwaEVP, CIO & CTO | Grant/Award | 750 | — | 2,940(D) | View → |
| Sep 1, 2026 | Sep 3 12:19 PM | Jonathan C MeltzerEVP, COO | Grant/Award | 900 | — | 3,594(D) | View → |
| Sep 1, 2026 | Sep 3 12:18 PM | Bryan T VaughnEVP and President, Diagnostics | Grant/Award | 1,500 | — | 5,204(D) | View → |
| Sep 1, 2026 | Sep 3 12:07 PM | Brian J CaveneyEVP, Pres of BLS, CMO & CSO | Grant/Award | 3,000 | — | 7,170(D) | View → |
| Aug 3, 2026 | Aug 5 3:17 PM | Peter J WilkinsonSVP, Chief Accounting Officer | Option Exercise | 1,338 | $209.25 | 0(D) | View → |
| Jul 1, 2026 | Jul 6 1:37 PM | Kathryn W KyleEVP, Chief Legal Officer | Option Exercise | 256 | — | 2,008(D) | View → |
| Jul 1, 2026 | Jul 6 1:36 PM | Bryan T VaughnEVP and President, Diagnostics | Option Exercise | 327 | — | 3,704(D) | View → |
| Feb 11, 2026 | Feb 13 6:19 PM | Amy B. SummyEVP, Chief Marketing Officer | Option Exercise | 230 | — | 1,304(D) | View → |
| Feb 11, 2026 | Feb 13 6:17 PM | Peter J WilkinsonSVP, Chief Accounting Officer | Option Exercise | 696 | — | 1,968(D) | View → |
| Feb 11, 2026 | Feb 13 6:16 PM | Julia Aijun WangChief Financial Officer, EVP | Option Exercise | 860 | — | 4,964(D) | View → |
| Feb 11, 2026 | Feb 13 6:15 PM | Bryan T VaughnEVP, Diagnostics | Option Exercise | 323 | — | 4,031(D) | View → |
| Feb 11, 2026 | Feb 13 6:14 PM | Der Vaart Sandra D VanEVP, Corporate Affairs | Option Exercise | 376 | — | 1,141(D) | View → |
| Feb 11, 2026 | Feb 13 6:13 PM | Mark S SchroederEVP, Pres Diagnostics & COO | Option Exercise | 806 | — | 2,358(D) | View → |
| Feb 11, 2026 | Feb 13 6:13 PM | Adam H SchechterDirector, President & CEO | Option Exercise | 3,656 | — | 22,214(D) | View → |
| Feb 11, 2026 | Feb 13 6:12 PM | Akinbolade OyegunwaEVP, CIO & CTO | Option Exercise | 230 | — | 2,190(D) | View → |
| Feb 11, 2026 | Feb 13 6:11 PM | Jonathan C MeltzerEVP, Operations | Option Exercise | 243 | — | 2,694(D) | View → |
| Feb 11, 2026 | Feb 13 6:10 PM | Kathryn W KyleEVP, Chief Legal Officer | Option Exercise | 216 | — | 2,264(D) | View → |
| Feb 11, 2026 | Feb 13 6:09 PM | Anita Z GrahamEVP, CHRO | Option Exercise | 356 | — | 2,401(D) | View → |
| Feb 11, 2026 | Feb 13 6:08 PM | Brian J CaveneyEVP, Pres of ED, CMO & CSO | Option Exercise | 740 | — | 4,170(D) | View → |
| Feb 11, 2026 | Feb 13 6:07 PM | Megan D. BaileyEVP, Pres, Central Labs & Intl | Option Exercise | 403 | — | 2,827(D) | View → |
Page 1 of 4
Next →